Strategies for the development of vaccines for typhoid fever, shigellosis, and cholera. 1989

S I Miller, and J J Mekalanos
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115.

UI MeSH Term Description Entries
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D012481 Salmonella Infections, Animal Infections in animals with bacteria of the genus SALMONELLA. Animal Salmonella Infection,Animal Salmonella Infections,Infection, Animal Salmonella,Infections, Animal Salmonella,Salmonella Infection, Animal
D012485 Salmonella typhi A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER. Salmonella enterica serovar Typhi,Salmonella typhosa
D012760 Shigella A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery (DYSENTERY, BACILLARY).
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D022121 Cholera Vaccines Vaccines or candidate vaccines used to prevent infection with VIBRIO CHOLERAE. The original cholera vaccine consisted of killed bacteria, but other kinds of vaccines now exist. Cholera Vaccine,Vaccine, Cholera,Vaccines, Cholera

Related Publications

S I Miller, and J J Mekalanos
December 2004, Expert opinion on biological therapy,
S I Miller, and J J Mekalanos
January 1975, Wiadomosci lekarskie (Warsaw, Poland : 1960),
S I Miller, and J J Mekalanos
November 2001, Nihon rinsho. Japanese journal of clinical medicine,
S I Miller, and J J Mekalanos
January 1979, Journal of biological standardization,
S I Miller, and J J Mekalanos
June 1999, Vaccine,
S I Miller, and J J Mekalanos
February 2000, Vaccine,
S I Miller, and J J Mekalanos
January 2000, The National medical journal of India,
S I Miller, and J J Mekalanos
May 2018, The Cochrane database of systematic reviews,
S I Miller, and J J Mekalanos
January 2014, The Cochrane database of systematic reviews,
Copied contents to your clipboard!